KindlyMD, a healthcare company listed on the Nasdaq, has announced its intention to register with the SEC for a substantial stock sale amounting up to $5 billion. The company aims to allocate a portion of the funds generated through this offering to expand its Bitcoin 
$62,585 reserves alongside other general corporate activities. Shares will be available for sale at market prices through TD Securities, Cantor Fitzgerald, and B. Riley Securities.
Flexible and Long-term Stock Sale Strategy
The at-the-market (ATM) stock sale program introduced by KindlyMD provides the company with the flexibility to raise capital at different times over a specific period without needing separate approvals for each issuance. This setup allows the company to gather funds from the market at its discretion regarding the timing and amount, whether through Nasdaq or at relevant prices. This method offers speed and flexibility, enabling the execution of the company’s strategic plans more effectively.
KindlyMD plans to prioritize the expansion of its Bitcoin reserves with the funds acquired from this venture. The company recently merged with Nakamoto Holdings, activating a crypto strategy, resulting in the initial acquisition of 5,744 BTC.
Growing Trend of Corporate Bitcoin Reserves
KindlyMD’s plan aligns with the growing interest in adding cryptocurrencies to corporate balance sheets, a trend notably championed by Michael Saylor’s company, Strategy. This movement has expanded with numerous companies integrating Bitcoin and Ethereum 
$1,756, among other cryptocurrencies, into their reserves. Currently, some businesses are diversifying their portfolios by including various cryptocurrencies such as Solana 
$82, BNB, and XRP.
In recent market activity, KindlyMD’s shares (NAKA) ended the trading day on Tuesday with a 12% decrease, closing at $8.07 according to Google Finance data. Meanwhile, the price of Bitcoin saw a 0.94% increase over the last 24 hours, trading at $111,263.
